Dr Sarah Laing
- Research Associate (CRUK Scotland Institute)
- Widening Participation Postgraduate Tutor (External Relations)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Munro, J., Gillen, S. L., Mitchell, L., Laing, S., Karim, S. A., Rink, C. J., Waldron, J. A. and Bushell, M. (2023) Optimisation of sample preparation from primary mouse tissue to maintain RNA integrity for methods examining translational control. Cancers, 15(15), 3985. (doi: 10.3390/cancers15153985) (PMID:37568801) (PMCID:PMC10417042)
Muthalagu, N. et al. (2020) Repression of the type I interferon pathway underlies MYC & KRAS-dependent evasion of NK & B cells in pancreatic ductal adenocarcinoma. Cancer Discovery, 10(6), pp. 872-887. (doi: 10.1158/2159-8290.CD-19-0620) (PMID:32200350) (PMCID:PMC7611248)
Kruspig, B. et al. (2018) The ERBB network facilitates KRAS-driven lung tumorigenesis. Science Translational Medicine, 10(446), eaao2565. (doi: 10.1126/scitranslmed.aao2565) (PMID:29925636) (PMCID:PMC6881183)
Munro, J., Gillen, S. L., Mitchell, L., Laing, S., Karim, S. A., Rink, C. J., Waldron, J. A. and Bushell, M. (2023) Optimisation of sample preparation from primary mouse tissue to maintain RNA integrity for methods examining translational control. Cancers, 15(15), 3985. (doi: 10.3390/cancers15153985) (PMID:37568801) (PMCID:PMC10417042)
Muthalagu, N. et al. (2020) Repression of the type I interferon pathway underlies MYC & KRAS-dependent evasion of NK & B cells in pancreatic ductal adenocarcinoma. Cancer Discovery, 10(6), pp. 872-887. (doi: 10.1158/2159-8290.CD-19-0620) (PMID:32200350) (PMCID:PMC7611248)
Kruspig, B. et al. (2018) The ERBB network facilitates KRAS-driven lung tumorigenesis. Science Translational Medicine, 10(446), eaao2565. (doi: 10.1126/scitranslmed.aao2565) (PMID:29925636) (PMCID:PMC6881183)